Serum thyroglobulin levels play a crucial role in the diagnosis and managem
ent of several thyroid disorders. This is particularly the case in the mana
gement of patients with differentiated thyroid cancer. Rational interpretat
ion of serum thyroglobulin (TG) levels requires a working knowledge of the
serum TG assay and its limitations. The ability to stimulate TC with rhTSH
during thyroid hormone suppression and to measure TG mRNA from peripheral b
lood holds promise for improvement in the management of thyroid cancer pati
ents over the next decade. This article will review the clinical use of ser
um TG in several thyroid disorders, with particular emphasis on the managem
ent of differentiated thyroid cancer. Thyroglobulin assay limitations and p
otential solutions to these problems also are discussed.